Assessing Maternal Post-partum Pain With Suppositories

• Status: Completed
• Trial end date: 2011-09-29
• Target enrollment: 0
• Participant gender: Female

Summary

This trial will evaluate whether the routine use of belladonna/opium (B&O) suppositories improve patients' self-reported pain control in the first 24-hours after delivery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loyola University
• Treatments: Glycerol

Criteria

Inclusion Criteria:

• Anticipated Vaginal or Cesarean delivery at Gottlieb Medical Center or Loyola University Medical Center

• > 34 weeks gestation at time of delivery

• > 18 years old

• No known allergy to belladonna, opium, or vegetable oil suppositories

• Able to consent and complete study documents

Exclusion Criteria:

• Chronic pain condition or on narcotic medication prior to admission

• Contraindications to B&O suppositories, including patients with glaucoma, severe hepatic, or renal disease; bronchial asthma; narcotic idiosyncrasies; respiratory depression; convulsive disorders; acute alcoholism; delirium tremens; history of hypersensitivity to any component of product.